Bionoia Where life meets thought
Back to Journal
Journal Stress biology
Discovery

Impact of Chronic Mild Stress on Neurotrophic and Hypothalamic-Pituitary-Adrenal Factors in the Brain of Rats Submitted to Sepsis

Speculation
Read original paper
Editor's note
Chronic stress and past infection both independently blunt the brain's production of growth factors essential for neuroplasticity and repair—a dual hit that may explain why survivors of sepsis often struggle with cognitive decline. This rat study clarifies mechanism rather than overturning existing doctrine, filling a gap between stress physiology and post-critical illness outcomes. Critical care teams and neuropsychiatrists tracking long-term sepsis sequelae should take note.

Source: europepmc · Origin: BR · Peper-Nascimento J, Possamai-Della T, Gois-Carvalho T, Aguiar-Geraldo JM, Pescador B, Quevedo J, Dal-Pizzol F, Valvassor · Neurotoxicity research · 2026-05-23

URL: https://pubmed.ncbi.nlm.nih.gov/42176200/

AI rationale (4/5, tier: preliminary): Measures HPA-axis markers (ACTH, corticosterone) under chronic stress in animal model; mechanism-focused but animal study limits direct translation.


The present study aimed to investigate the effects of chronic mild stress (CMS) on neurotrophic factors in the brains of rats subjected to the cecal ligation and puncture (CLP) model of sepsis. After 30 days of the CLP procedure, the animals were subjected to CMS. Twenty-four hours after the last stressor, the animals were euthanized, their blood was collected, and their brains were dissected in the frontal cortex and hippocampus. Then, the levels of brain-derived neurotrophic factor, neurotrophin-3, neurotrophin-4, nerve growth factor, and glial cell line-derived neurotrophic factor were evaluated in the brain structures. The levels of adrenocorticotropic hormone and corticosterone were evaluated in the serum of the rats. The four experimental groups of the present study were: (1) Sham + Non-stressed; (2) Sepsis + Non-stressed; (3) Sham + CMS; (4) Sepsis + CMS. CMS increased adrenocorticotropic hormone and corticosterone levels, whereas sepsis alone did not significantly alter these hormones. Regarding neurotrophic factors, CMS reduced the levels of BDNF, NT-3, NT-4, and NGF in both the hippocampus and frontal cortex, regardless of prior sepsis exposure. Sepsis alone was also associated with reduced levels of these neurotrophins, although the magnitude of the effect varied depending on the specific neurotrophin and brain region, with greater reductions observed for BDNF and NGF. No interaction between sepsis and CMS was detected for these neurotrophins, suggesting independent effects. Our findings suggest that sepsis and CMS independently affect most neurotrophin levels, with no clear evidence that prior sepsis potentiates the effects of subsequent CMS. GDNF represents an exception, pointing to potential region-specific mechanisms that warrant further investigation.

🔬 Deep dive

Plain-language summary

This study asked whether surviving sepsis makes the brain more vulnerable to a subsequent period of chronic stress. Researchers used a well-established rat model of sepsis (cecal ligation and puncture, CLP) and then, 30 days later, exposed the animals to a month of unpredictable mild stressors. They measured five key brain-support proteins—neurotrophins—in the hippocampus and frontal cortex, and sampled stress hormones (ACTH and corticosterone) from blood. Both sepsis history and chronic mild stress independently reduced neurotrophin levels in the brain, but the two insults did not noticeably compound each other for most proteins measured. Chronic mild stress was the stronger driver of hormonal dysregulation, raising ACTH and corticosterone significantly, while sepsis alone left these hormones largely unchanged at the 30-day mark. One protein, GDNF (glial cell line-derived neurotrophic factor), behaved differently and showed hints of a region-specific interaction, flagging it as a target for follow-up work. The findings matter because post-sepsis psychiatric and cognitive problems are common clinically, and understanding whether prior sepsis sensitizes the stress axis could inform monitoring strategies for survivors.

Key findings

  • Chronic mild stress (CMS) significantly elevated serum ACTH and corticosterone levels in both sham and sepsis-surviving rats; sepsis alone (30 days post-CLP) did not produce significant changes in either hormone at the time of measurement.
  • CMS reduced BDNF, NT-3, NT-4, and NGF levels in both the hippocampus and frontal cortex regardless of sepsis history; sepsis alone also reduced these neurotrophins, with BDNF and NGF showing the largest magnitude of decrease.
  • No statistically significant interaction between prior sepsis and CMS was detected for BDNF, NT-3, NT-4, or NGF, indicating largely independent rather than synergistic effects on these neurotrophins.
  • GDNF was identified as an exception: its response pattern suggested possible region-specific interaction between sepsis and CMS, distinguishing it mechanistically from the other neurotrophins studied.

Methods + cohort

This is a controlled animal experiment using adult male Wistar rats allocated to four groups: Sham + Non-stressed, Sepsis + Non-stressed, Sham + CMS, and Sepsis + CMS. Sepsis was induced via cecal ligation and puncture (CLP); after a 30-day recovery period, CMS was applied for an unspecified duration of repeated unpredictable mild stressors. Twenty-four hours after the final stressor, animals were euthanized, serum was collected for ACTH and corticosterone assay, and brains were dissected into frontal cortex and hippocampus for neurotrophin quantification (BDNF, NT-3, NT-4, NGF, GDNF). Exact group sizes are not reported in the abstract.

Limitations + open questions

As an animal study using the CLP model, findings may not translate directly to human sepsis, which varies widely in severity, pathogen, and clinical management. The study reports a single post-CMS timepoint, so it cannot address whether neurotrophin reductions are transient or permanent, nor whether they precede or follow behavioral changes. Group sizes and statistical power are not detailed in the abstract, limiting assessment of whether the null interaction finding reflects a true absence of synergy or insufficient power. The next critical experiment would be a longitudinal design tracking neurotrophin trajectories from sepsis onset through stress exposure, paired with behavioral endpoints (e.g., anxiety, cognitive testing), and ideally replicated across sexes and sepsis severities.

How this fits the corpus

This study extends [§67] (stress during the first 1,000 days of life), which establishes that early biological stress programs long-term HPA-axis reactivity, by probing the analogous question in adulthood: whether a major physiological stressor (sepsis) permanently sensitizes HPA circuitry to subsequent psychological stress—here it finds largely independent rather than cumulative effects. The neurotrophin-reduction findings parallel [§130], which examines hippocampal and cortical molecular changes under metabolic stress in rat models, reinforcing that diverse physiological insults converge on neurotrophin downregulation in the same brain regions. The HPA-axis hormonal data (ACTH, corticosterone elevation under CMS) also connect mechanistically to [§93], where allostatic load and its inflammatory correlates are quantified in a clinical context, suggesting that the rat CMS model recapitulates a core hormonal signature of human allostatic burden. Taken together, this article occupies a niche within the corpus as one of the few studies using a double-hit animal design to disentangle sepsis-specific from stress-general effects on brain neurotrophic support.

Compare with

AI-generated summary using claude-sonnet-4-6 on 2026-07-06. Information, not medical advice.
Published 2026-05-28 · Last kit-update 2026-05-28